Spontaneous recombinase activity of Cre-ERT2 in vivo

被引:46
|
作者
Kristianto, Jasmin [1 ,2 ]
Johnson, Michael G. [4 ]
Zastrow, Ryley K. [4 ]
Radcliff, Abigail B. [4 ]
Blank, Robert D. [1 ,2 ,3 ]
机构
[1] Med Coll Wisconsin, Dept Med, Milwaukee, WI 53226 USA
[2] William S Middleton Mem Vet Adm Med Ctr, Madison, WI USA
[3] Milwaukee VA Med Ctr, Milwaukee, WI USA
[4] Univ Wisconsin, Dept Med, Sch Med & Publ Hlth, Madison, WI USA
关键词
Tamoxifen; Estrogen receptor; Recombination; Cre-activity; TETRACYCLINE-RESPONSIVE PROMOTERS; GENE-EXPRESSION; TIGHT CONTROL; MICE; MUTAGENESIS; VECTORS; CELLS;
D O I
10.1007/s11248-017-0018-1
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Inducible Cre-ERT recombinase technology is widely used for gene targeting studies. The second generation of inducible Cre-ERT recombinase, hemizygous B6.129S-Tg(UBC-cre/ERT2)1Ejb/J (hereafter abbreviated as Cre-ERT2), a fusion of a mutated estrogen receptor and Cre recombinase, was engineered to be more efficient and specific than the original Cre-ERT. The putative mechanism of selective Cre-mediated recombination is Cre sequestration in the cytoplasm in the basal state with translocation to the nucleus only in the presence of tamoxifen. We utilized both a reporter mouse (B6.129 (Cg)-Gt(ROSA)26Sor (tm4(ACTB-tdTomato,-EGFP)Luo) /J) and endothelin converting enzyme-1 floxed transgenic mouse line to evaluate Cre-ERT2 activity. We observed spontaneous Cre activity in both settings. Unintended Cre activity is a confounding factor that has a potentially large impact on data interpretation. Thus, it is important to consider background Cre activity in experimental design.
引用
收藏
页码:411 / 417
页数:7
相关论文
共 50 条
  • [1] Spontaneous recombinase activity of Cre–ERT2 in vivo
    Jasmin Kristianto
    Michael G. Johnson
    Ryley K. Zastrow
    Abigail B. Radcliff
    Robert D. Blank
    Transgenic Research, 2017, 26 : 411 - 417
  • [2] Temporally-controlled site-specific mutagenesis in the basal layer of the epidermis:: comparison of the recombinase activity of the tamoxifen-inducible Cre-ERT and Cre-ERT2 recombinases
    Indra, AK
    Warot, X
    Brocard, J
    Bornert, JM
    Xiao, JH
    Chambon, P
    Metzger, D
    NUCLEIC ACIDS RESEARCH, 1999, 27 (22) : 4324 - 4327
  • [3] Spatiotemporal gene control by the Cre-ERT2 system in melanocytes
    Yajima, I
    Belloir, E
    Bourgeois, Y
    Kumasaka, M
    Delmas, V
    Larue, L
    GENESIS, 2006, 44 (01) : 34 - 43
  • [4] A Series of Cre-ERT2 Drivers for Manipulation of the Skeletal Muscle Lineage
    Southard, Sheryl
    Low, SiewHui
    Li, Lydia
    Rozo, Michelle
    Harvey, Tyler
    Fan, Chen-Ming
    Lepper, Christoph
    GENESIS, 2014, 52 (08) : 759 - 770
  • [5] Impaired adipogenesis and lipolysis in the mouse upon selective ablation of the retinoid X receptor α mediated by a tamoxifen-inducible chimeric Cre recombinase (Cre-ERT2) in adipocytes
    Imai, T
    Jiang, M
    Chambon, P
    Metzger, D
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (01) : 224 - 228
  • [6] Generation and Initial Characterization of a c-KIT Cre-ERT2 Mouse Model
    Nagl, F.
    Schneider, G.
    Seidler, B.
    Schmid, R. M.
    Saur, D.
    LABORATORY INVESTIGATION, 2009, 89 : 141A - 141A
  • [7] Generation and Initial Characterization of a c-KIT Cre-ERT2 Mouse Model
    Nagl, F.
    Schneider, G.
    Seidler, B.
    Schmid, R. M.
    Saur, D.
    MODERN PATHOLOGY, 2009, 22 : 141A - 141A
  • [8] Inducible and tissue-specific cell labeling in Cre-ERT2 transgenic Xenopus lines
    Lin, Tzi-Yang
    Taniguchi-Sugiura, Yuka
    Murawala, Prayag
    Hermann, Sarah
    Tanaka, Elly M.
    DEVELOPMENT GROWTH & DIFFERENTIATION, 2022, 64 (05) : 243 - 253
  • [9] Characterization of Cre Recombinase Activity for In Vivo Targeting of Adipocyte Precursor Cells
    Krueger, Katherine C.
    Costa, Maria Jose
    Du, Hongqing
    Feldman, Brian J.
    STEM CELL REPORTS, 2014, 3 (06): : 1147 - 1158
  • [10] Agroinfiltration as a Tool for Transient Expression of cre Recombinase in vivo
    Lilya Kopertekh
    Joachim Schiemann
    Transgenic Research, 2005, 14 : 793 - 798